Oligonucleotide Purification Solutions - Agilent PLRP-S and PL-SAX HPLC columns

Importance of the Topic

The development of synthetic oligonucleotides underpins advances in therapeutics, genomics and diagnostics, including RNA-based drugs and next-generation sequencing. Reliable purification and analytics are critical to ensure molecular integrity, sequence fidelity, and removal of impurities across a diverse range of oligonucleotide sizes and chemistries.

Study Objectives and Overview

This work evaluates Agilent’s polymeric HPLC columns, PLRP-S for ion pair reversed-phase and PL-SAX for strong anion exchange, to address scalable purification and analysis of oligonucleotides from small siRNA to large mRNA. It outlines method development strategies, thermal and chemical stability, binding capacities, and scale-up potential.

Methodology and Instrumentation

• Ion-pair reversed-phase separations on PLRP-S columns with pore sizes from 100 Å to 4000 Å. Techniques include high-temperature operation and HFIP-based mobile phases for enhanced mass transfer and denaturing conditions.
• Anion-exchange separations on PL-SAX columns with 1000 Å and 4000 Å pores using Tris or TEAA buffers, organic modifiers, and elevated pH to resolve phosphodiester species and guide RNA.
• Scale-up studies from analytical (2.1×50 mm) to preparative and bulk formats (up to 100×300 mm) with load capacities guided by dynamic binding capacity measurements.

Used Instrumentation

• Agilent 1290 Infinity II LC system and preparative LC for method development and purification.
• Agilent AdvanceBio 6545XT LC/Q-TOF for intact RNA and poly(A) tail analysis.
• UV detectors at 260 nm and mass-based triggers for fraction collection.

Key Results and Discussion

• PLRP-S columns demonstrated robust performance at up to 80 °C and wide pH, with binding capacities matched to oligonucleotide size and pore dimensions.
• PL-SAX columns provided high-resolution separation of crude oligonucleotides and therapeutic guide RNA under denaturing conditions, with dynamic binding capacities suitable for scale-up.
• Scale-up data showed predictable loading based on 5 % of dynamic binding capacity, enabling transitions from analytical to bulk purifications with consistent chemistry.

Benefits and Practical Applications

• Robust polymeric stationary phases resist chemical degradation and support denaturing or high-pH conditions.
• Wide range of pore and particle sizes accommodates molecules from 18 bases to thousands of bases.
• Seamless scalability from analytical to pilot and production scales minimizes method transfer issues.

Future Trends and Opportunities

Continued innovation in polymeric HPLC media, integration with automated platforms, and adoption of novel buffer systems will expand purification capabilities for emerging oligonucleotide therapeutics, gene editing components, and complex biologics. Enhanced coupling with real-time analytics and continuous processing may further improve throughput and quality control.

Conclusion

Agilent’s PLRP-S and PL-SAX columns deliver versatile, scalable, and chemically resilient solutions for oligonucleotide purification and analysis. Their broad operational range and predictable scale-up pathways support the demands of research, quality control, and manufacturing across diverse oligonucleotide-based technologies.